Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth Love

Showing results (141-150 of 208) with videos related to

Pageof 21
Sort By:
Plos One|November 9, 2013
BIN1 is decreased in sporadic but not familial Alzheimer's disease or in agingElizabeth B C Glennon, Isobel J Whitehouse, J Scott Miners, et al.
Plos One|April 12, 2013
Prion protein is decreased in Alzheimer's brain and inversely correlates with BACE1 activity, amyloid-β levels and Braak stageIsobel J Whitehouse, J Scott Miners, Elizabeth B C Glennon, et al.
Lancet (London, England)|January 24, 2021
Neuropathology associated with SARS-CoV-2 infectionKristof Egervari, Christian Thomas, Johannes A Lobrinus, et al.
Annals of Neurology|October 2, 2003
Retrograde reactions of Clarke's nucleus neurons after human spinal cord injuryAndreas B Schmitt, Sebastian Breuer, Leyla Polat, et al.
International Journal of Molecular Epidemiology and Genetics|May 4, 2011
LRP-1 variation is not associated with risk of Alzheimer's diseaseKaty A Chalmers, Rachel Barker, Peter A Passmore, et al.
Brain : a Journal of Neurology|June 4, 2019
Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer's diseaseJames A R Nicoll, George R Buckland, Charlotte H Harrison, et al.
Brain : a Journal of Neurology|August 15, 2013
Inflammatory components in human Alzheimer's disease and after active amyloid-β42 immunizationElina Zotova, Viraj Bharambe, Matthew Cheaveau, et al.
Plos One|November 10, 2012
CNS SIRT3 expression is altered by reactive oxygen species and in Alzheimer's diseaseHeather J M Weir, Tracey K Murray, Patrick G Kehoe, et al.
Journal of Alzheimer'S Disease : JAD|July 4, 2012
Convection-enhanced delivery of neprilysin: a novel amyloid-β-degrading therapeutic strategyNeil U Barua, J Scott Miners, Alison S Bienemann, et al.
American Journal of Translational Research|March 19, 2011
Angiotensin II-inhibiting drugs have no effect on intraneuronal Aβ or oligomeric Aβ levels in a triple transgenic mouse model of Alzheimer's diseaseLinda Ferrington, J Scott Miners, Laura E Palmer, et al.
Pageof 21

Showing results (141-150 of 208) with videos related to

Sort By:
Pageof 21
Plos One|November 9, 2013
BIN1 is decreased in sporadic but not familial Alzheimer's disease or in agingElizabeth B C Glennon, Isobel J Whitehouse, J Scott Miners, et al.
Plos One|April 12, 2013
Prion protein is decreased in Alzheimer's brain and inversely correlates with BACE1 activity, amyloid-β levels and Braak stageIsobel J Whitehouse, J Scott Miners, Elizabeth B C Glennon, et al.
Lancet (London, England)|January 24, 2021
Neuropathology associated with SARS-CoV-2 infectionKristof Egervari, Christian Thomas, Johannes A Lobrinus, et al.
Annals of Neurology|October 2, 2003
Retrograde reactions of Clarke's nucleus neurons after human spinal cord injuryAndreas B Schmitt, Sebastian Breuer, Leyla Polat, et al.
International Journal of Molecular Epidemiology and Genetics|May 4, 2011
LRP-1 variation is not associated with risk of Alzheimer's diseaseKaty A Chalmers, Rachel Barker, Peter A Passmore, et al.
Brain : a Journal of Neurology|June 4, 2019
Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer's diseaseJames A R Nicoll, George R Buckland, Charlotte H Harrison, et al.
Brain : a Journal of Neurology|August 15, 2013
Inflammatory components in human Alzheimer's disease and after active amyloid-β42 immunizationElina Zotova, Viraj Bharambe, Matthew Cheaveau, et al.
Plos One|November 10, 2012
CNS SIRT3 expression is altered by reactive oxygen species and in Alzheimer's diseaseHeather J M Weir, Tracey K Murray, Patrick G Kehoe, et al.
Journal of Alzheimer'S Disease : JAD|July 4, 2012
Convection-enhanced delivery of neprilysin: a novel amyloid-β-degrading therapeutic strategyNeil U Barua, J Scott Miners, Alison S Bienemann, et al.
American Journal of Translational Research|March 19, 2011
Angiotensin II-inhibiting drugs have no effect on intraneuronal Aβ or oligomeric Aβ levels in a triple transgenic mouse model of Alzheimer's diseaseLinda Ferrington, J Scott Miners, Laura E Palmer, et al.
Pageof 21